Sarissa Capital Management as of June 30, 2022
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 42.1 | $418M | 14M | 29.79 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 19.0 | $189M | 16M | 11.53 | |
| Biogen Idec (BIIB) | 13.2 | $131M | 643k | 203.94 | |
| Innoviva (INVA) | 9.8 | $98M | 6.6M | 14.76 | |
| Gilead Sciences (GILD) | 8.3 | $83M | 1.3M | 61.81 | |
| Amarin Corp Spons Adr New (AMRN) | 3.6 | $36M | 24M | 1.49 | |
| Mersana Therapeutics (MRSN) | 2.0 | $20M | 4.3M | 4.62 | |
| BioCryst Pharmaceuticals (BCRX) | 1.5 | $15M | 1.4M | 10.58 | |
| Vor Biopharma (VOR) | 0.3 | $3.1M | 618k | 4.97 | |
| Pear Therapeutics Class A Com | 0.1 | $771k | 500k | 1.54 | |
| Regulus Therapeutics (RGLS) | 0.0 | $383k | 185k | 2.07 |
